| Business Summary | | Priority
Healthcare
Corporation
is
a
national
distributor
of
specialty
pharmaceuticals
and
related
medical
supplies
to
the
alternate
site
healthcare
market,
and
is
a
provider
of
patient-specific,
self-injectable
biopharmaceuticals
and
disease
treatment
programs
to
individuals
with
chronic
diseases.
With
the
acquisition
of
Freedom
Drug,
the
Company
is
also
a
major
infertility
specialty
pharmacy.
Through
Priority
Healthcare
Distribution,
the
Company
sells
over
3,500
SKUs
of
specialty
pharmaceuticals
and
medical
supplies
to
outpatient
renal
care
centers
and
office-based
physicians
in
oncology
and
other
physician
specialty
markets.
Priority
Healthcare
Distribution
offers
services
to
meet
the
specific
needs
of
these
markets
by
shipping
refrigerated
pharmaceuticals
overnight
in
special
packaging
to
maintain
appropriate
temperatures,
offering
automated
order
entry
services
and
offering
customized
distribution
for
group
accounts. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PHCC
distributes
specialty
pharmaceuticals
and
related
medical
supplies
to
the
alternate
site
healthcare
market
and
provides
patient
specific,
self
injectable
biopharmaceuticals
and
disease
treatment
programs.
For
the
six
months
ended
6/30/01,
revenues
rose
30%
to
$368.9
million.
Net
income
fell
15%
to
$11.8
million.
Results
reflect
the
acquisitions
of
Freedom
Drug
and
Physicians
Formulary
and
higher
prices,
offset
by
higher
bad
debt
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Willliam Bindley, 60 Chairman | -- | -- | Steven Cosler, 45 Pres,
COO, Director | $320K | $3.1M | Robert Myers, 55 Vice
Chairman, CEO | 625K | 10.6M | Donald Perfetto, 54 Exec.
VP, CFO, Treasurer | 283K | 2.4M | Guy Bryant, 42 Exec.
VP and CMO | 274K | 2.6M | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|